Drug Type Small molecule drug |
Synonyms- |
Target- |
Action donors |
Mechanism H2S donor(Hydrogen sulfide donor) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H24N4O6S |
InChIKeyCKXHSFVSCMKDBN-UHFFFAOYSA-N |
CAS Registry3059571-05-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myocardial Ischemia | Preclinical | China | 25 Jun 2025 | |
| Reperfusion Injury | Preclinical | China | 25 Jun 2025 |





